127 related articles for article (PubMed ID: 32485433)
1. Brain metabolic changes in patients with treatment resistant schizophrenia treated with deep brain stimulation: A series of cases.
Roldán A; Portella MJ; Sampedro F; Alonso-Solís A; Sarró S; Rabella M; Grasa EM; Álvarez E; Rodríguez R; Camacho V; Fernandez-León A; Fuentes F; Pérez-Blanco J; Pérez V; Mckenna P; Pomarol-Clotet E; Corripio I
J Psychiatr Res; 2020 Aug; 127():57-61. PubMed ID: 32485433
[TBL] [Abstract][Full Text] [Related]
2. Deep brain stimulation improves behavior and modulates neural circuits in a rodent model of schizophrenia.
Bikovsky L; Hadar R; Soto-Montenegro ML; Klein J; Weiner I; Desco M; Pascau J; Winter C; Hamani C
Exp Neurol; 2016 Sep; 283(Pt A):142-50. PubMed ID: 27302677
[TBL] [Abstract][Full Text] [Related]
3. Differences in metabolic network modulation between capsulotomy and deep-brain stimulation for refractory obsessive-compulsive disorder.
Suetens K; Nuttin B; Gabriëls L; Van Laere K
J Nucl Med; 2014 Jun; 55(6):951-9. PubMed ID: 24722531
[TBL] [Abstract][Full Text] [Related]
4. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression.
Bewernick BH; Hurlemann R; Matusch A; Kayser S; Grubert C; Hadrysiewicz B; Axmacher N; Lemke M; Cooper-Mahkorn D; Cohen MX; Brockmann H; Lenartz D; Sturm V; Schlaepfer TE
Biol Psychiatry; 2010 Jan; 67(2):110-6. PubMed ID: 19914605
[TBL] [Abstract][Full Text] [Related]
5. Response to Deep Brain Stimulation in Three Brain Targets with Implications in Mental Disorders: A PET Study in Rats.
Casquero-Veiga M; Hadar R; Pascau J; Winter C; Desco M; Soto-Montenegro ML
PLoS One; 2016; 11(12):e0168689. PubMed ID: 28033356
[TBL] [Abstract][Full Text] [Related]
6. Deep brain stimulation in treatment resistant schizophrenia: A pilot randomized cross-over clinical trial.
Corripio I; Roldán A; Sarró S; McKenna PJ; Alonso-Solís A; Rabella M; Díaz A; Puigdemont D; Pérez-Solà V; Álvarez E; Arévalo A; Padilla PP; Ruiz-Idiago JM; Rodríguez R; Molet J; Pomarol-Clotet E; Portella MJ
EBioMedicine; 2020 Jan; 51():102568. PubMed ID: 31927311
[TBL] [Abstract][Full Text] [Related]
7. Target selection for deep brain stimulation in treatment resistant schizophrenia.
Corripio I; Roldán A; McKenna P; Sarró S; Alonso-Solís A; Salgado L; Álvarez E; Molet J; Pomarol-Clotet E; Portella M
Prog Neuropsychopharmacol Biol Psychiatry; 2022 Jan; 112():110436. PubMed ID: 34517055
[TBL] [Abstract][Full Text] [Related]
8. Limbic versus cognitive target for deep brain stimulation in treatment-resistant depression: accumbens more promising than caudate.
Millet B; Jaafari N; Polosan M; Baup N; Giordana B; Haegelen C; Chabardes S; Fontaine D; Devaux B; Yelnik J; Fossati P; Aouizerate B; Krebs MO; Robert G; Jay T; Cornu P; Vérin M; Drapier S; Drapier D; Sauleau P; Peron J; Le Jeune F; Naudet F; Reymann JM
Eur Neuropsychopharmacol; 2014 Aug; 24(8):1229-39. PubMed ID: 24950819
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of deep brain stimulation for treatment-resistant schizophrenia: Exploring potential targets.
Aibar-Durán JÁ; Corripio Collado I; Roldán Bejarano A; Sánchez Nevado R; Aracil Bolanos I; García-Cornet J; Alonso-Solís A; Grasa Bello EM; de Quintana Schmidt C; Muñoz Hernández F; Molet Teixidó J; Rodríguez RR
J Psychiatr Res; 2023 Jul; 163():296-304. PubMed ID: 37245316
[TBL] [Abstract][Full Text] [Related]
10. Acute and chronic changes in brain activity with deep brain stimulation for refractory depression.
Conen S; Matthews JC; Patel NK; Anton-Rodriguez J; Talbot PS
J Psychopharmacol; 2018 Apr; 32(4):430-440. PubMed ID: 29228889
[TBL] [Abstract][Full Text] [Related]
11. Deep brain stimulation of the nucleus accumbens in the treatment of severe alcohol use disorder: a phase I pilot trial.
Davidson B; Giacobbe P; George TP; Nestor SM; Rabin JS; Goubran M; Nyman AJ; Baskaran A; Meng Y; Pople CB; Graham SJ; Tam F; Hamani C; Lipsman N
Mol Psychiatry; 2022 Oct; 27(10):3992-4000. PubMed ID: 35858989
[TBL] [Abstract][Full Text] [Related]
12. Nucleus accumbens deep brain stimulation results in insula and prefrontal activation: a large animal FMRI study.
Knight EJ; Min HK; Hwang SC; Marsh MP; Paek S; Kim I; Felmlee JP; Abulseoud OA; Bennet KE; Frye MA; Lee KH
PLoS One; 2013; 8(2):e56640. PubMed ID: 23441210
[TBL] [Abstract][Full Text] [Related]
13. Nucleus accumbens deep brain stimulation for a patient with self-injurious behavior and autism spectrum disorder: functional and structural changes of the brain: report of a case and review of literature.
Park HR; Kim IH; Kang H; Lee DS; Kim BN; Kim DG; Paek SH
Acta Neurochir (Wien); 2017 Jan; 159(1):137-143. PubMed ID: 27807672
[TBL] [Abstract][Full Text] [Related]
14. Long-term results after deep brain stimulation of nucleus accumbens and the anterior limb of the internal capsule for preventing heroin relapse: An open-label pilot study.
Chen L; Li N; Ge S; Lozano AM; Lee DJ; Yang C; Li L; Bai Q; Lu H; Wang J; Wang X; Li J; Jing J; Su M; Wei L; Wang X; Gao G
Brain Stimul; 2019; 12(1):175-183. PubMed ID: 30245163
[TBL] [Abstract][Full Text] [Related]
15. Differences in functional connectivity profiles as a predictor of response to anterior thalamic nucleus deep brain stimulation for epilepsy: a hypothesis for the mechanism of action and a potential biomarker for outcomes.
Middlebrooks EH; Grewal SS; Stead M; Lundstrom BN; Worrell GA; Van Gompel JJ
Neurosurg Focus; 2018 Aug; 45(2):E7. PubMed ID: 30064322
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological and imaging evidence of sustained inhibition in limbic and frontal networks following deep brain stimulation for treatment refractory obsessive compulsive disorder.
Park HR; Kim IH; Kang H; McCairn KW; Lee DS; Kim BN; Kim DG; Paek SH
PLoS One; 2019; 14(7):e0219578. PubMed ID: 31323037
[TBL] [Abstract][Full Text] [Related]
17. Anterior thalamic nucleus stimulation modulates regional cerebral metabolism: an FDG-MicroPET study in rats.
Gao F; Guo Y; Zhang H; Wang S; Wang J; Wu JM; Chen Z; Ding MP
Neurobiol Dis; 2009 Jun; 34(3):477-83. PubMed ID: 19303441
[TBL] [Abstract][Full Text] [Related]
18. Safety and feasibility clinical trial of nucleus accumbens deep brain stimulation for treatment-refractory opioid use disorder.
Rezai AR; Mahoney JJ; Ranjan M; Haut MW; Zheng W; Lander LR; Berry JH; Farmer DL; Marton JL; Tirumalai P; Mears A; Thompson-Lake DGY; Finomore VS; D'Haese PF; Aklin WM; George DT; Corrigan JD; Hodder SL
J Neurosurg; 2024 Jan; 140(1):231-239. PubMed ID: 37329519
[TBL] [Abstract][Full Text] [Related]
19. Schizophrenia and neurosurgery: systematic review and theories.
Dutta RR; Picton B; Brown NJ; Yang C; Lee M; Sung H; Lopez AM; Paff M
Neurosurg Focus; 2023 Feb; 54(2):E7. PubMed ID: 36724524
[TBL] [Abstract][Full Text] [Related]
20. Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease.
Kalbe E; Voges J; Weber T; Haarer M; Baudrexel S; Klein JC; Kessler J; Sturm V; Heiss WD; Hilker R
Neurology; 2009 Jan; 72(1):42-9. PubMed ID: 19122029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
